This case study explores how IQVIA supports oncology research by integrating scientific expertise with advanced eCOA technology to capture comprehensive patient experience data aligned with evolving FDA guidance. As regulators increasingly require patient-reported outcomes throughout the drug development lifecycle, IQVIA enables sponsors to design fit-for-purpose Clinical Outcome Assessment (COA) strategies and deploy scalable, patient-centric data collection solutions. The platform includes flexible interfaces, bring-your-own-device capabilities, real-time monitoring, and access to a vast library of validated instruments, reducing patient burden while improving compliance and data quality. IQVIA’s approach accelerates eCOA deployment by up to 50%, enhances regulatory readiness, and ensure

Join for free to read